BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 16163188)

  • 21. Erythropoietin treatment of anemia associated with multiple myeloma.
    Ludwig H; Fritz E; Kotzmann H; Höcker P; Gisslinger H; Barnas U
    N Engl J Med; 1990 Jun; 322(24):1693-9. PubMed ID: 2342535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin.
    Mittelman M
    Isr J Med Sci; 1996 Dec; 32(12):1201-6. PubMed ID: 9007154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anemia in critical illness.
    Eckardt KU
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):84-9. PubMed ID: 11253745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of bone marrow cellularity during erythropoietin treatment in myeloma.
    Ludwig H; Chott A; Fritz E; Krainer M
    Stem Cells; 1995 Aug; 13 Suppl 2():77-87. PubMed ID: 8520516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
    Barlogie B
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of erythropoietin therapy in the critically ill.
    Corwin HL
    Transfus Med Rev; 2006 Jan; 20(1):27-33. PubMed ID: 16373185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anemia in head and neck cancers].
    Azria D; Zouhair A; Serre A; Lemanski C; Schneider M; Ozsahin M; Dubois JB; Lartigau E;
    Bull Cancer; 2005 May; 92(5):445-51. PubMed ID: 15932808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial experience using erythropoietin during radiation therapy.
    Lavey RS
    Strahlenther Onkol; 1998 Dec; 174 Suppl 4():24-30. PubMed ID: 9879344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma.
    San Miguel JF; García-Sanz R
    Med Oncol; 1998 Aug; 15 Suppl 1():S29-34. PubMed ID: 9785334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
    Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
    Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease].
    Longo G; Fiorani C; Bonacorsi G; Vanzanelli P; Sani F; Bevini M; Curci G; Torelli U
    Recenti Prog Med; 1992; 83(7-8):449-54. PubMed ID: 1529159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anemia and chemotherapy of malignant hemopathies].
    Damaj G; Braud AC; Hermine O
    Bull Cancer; 2003 Apr; 90 Spec No():S144-51. PubMed ID: 12856426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human erythropoietin for HIV-related anemia.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):18-24. PubMed ID: 11365957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Improvement of the anemia associated with multiple myeloma and renal dysfunction by recombinant human erythropoietin].
    Nakata H; Matsuzaki M; Shimamoto Y; Yamaguchi M
    Rinsho Ketsueki; 1990 Oct; 31(10):1752-3. PubMed ID: 2255069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alfa-epoietin and anaemia in gynaecological cancer.
    Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
    Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?
    Prutchi-Sagiv S; Golishevsky N; Oster HS; Katz O; Cohen A; Naparstek E; Neumann D; Mittelman M
    Br J Haematol; 2006 Dec; 135(5):660-72. PubMed ID: 17107348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of anemia correction by recombinant human erythropoietin in predialysis patients with renal failure.
    Sapojnikov M; Veksler A; Yagil Y; Kogan J; Turkot S; Boris G; Oren S
    Ren Fail; 2005; 27(2):199-203. PubMed ID: 15807186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin.
    Strauss RG
    Transfus Med Rev; 2006 Jan; 20(1):34-44. PubMed ID: 16373186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations.
    Ludwig H; Rai K; Blade J; Dammacco F; Degos L; Itri L; Kyle R; Liso V; Littlewood TJ; Mandelli F; Meloni G; Molica S; Osterborg A; Pangalis GA; San Miguel J; Schmitt B; Voliotis D
    Hematol J; 2002; 3(3):121-30. PubMed ID: 12111647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.